Stock data
Ernexa Therapeutics Inc. (ERNA)
Ernexa Therapeutics Inc. (ERNA) reported net income of -US$14.08M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$9.32M | -US$14.08M | — |
| 2024 | US$0.58M | US$0.49M | -US$15.67M | -US$44.54M | — |
| 2023 | US$0.07M | -US$0.17M | -US$21.14M | -US$21.67M | — |
| 2022 | US$0.00M | US$0.00M | -US$33.22M | -US$24.58M | — |
| 2021 | — | — | -US$113.73M | -US$122.55M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$4.01M | — |
| 2026-03-31 | — | -US$5.51M | — |
| 2025-12-31 | — | -US$1.50M | — |
| 2025-09-30 | — | -US$1.24M | — |
| 2025-06-30 | — | -US$3.14M | — |
| 2025-03-31 | — | -US$8.20M | — |
| 2024-12-31 | US$0.00M | -US$5.76M | — |
| 2024-09-30 | US$0.49M | -US$26.60M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.